Literature DB >> 22752026

Similar patterns of myocardial metabolism and perfusion in patients with type 2 diabetes and heart disease of ischaemic and non-ischaemic origin.

S Masi1, R Lautamäki, L Guiducci, P Di Cecco, C Porciello, S Pardini, M A Morales, V Chubuchny, P A Salvadori, M Emdin, A M Sironi, J Knuuti, D Neglia, P Nuutila, E Ferrannini, P Iozzo.   

Abstract

AIMS/HYPOTHESIS: Type 2 diabetes and insulin resistance are often associated with the co-occurrence of coronary atherosclerosis and cardiac dysfunction. The aim of this study was to define the independent relationships between left ventricular dysfunction or ischaemia and patterns of myocardial perfusion and metabolism in type 2 diabetes.
METHODS: Twenty-four type 2 diabetic patients--12 with coronary artery disease (CAD) and preserved left ventricular function and 12 with non-ischaemic heart failure (HF)--were enrolled in a cross-sectional study. Positron emission tomography (PET) was used to assess myocardial blood flow (MBF) at rest, after pharmacological stress and under euglycaemic hyperinsulinaemia. Insulin-mediated myocardial glucose disposal was determined with 2-deoxy-2-[(18)F]fluoroglucose PET.
RESULTS: There was no difference in myocardial glucose uptake (MGU) between the healthy myocardium of CAD patients and the dysfunctional myocardium of HF patients. MGU was strongly influenced by levels of systemic insulin resistance in both groups (CAD, r = 0.85, p = 0.005; HF, r = 0.77, p = 0.01). In HF patients, there was an inverse association between MGU and the coronary flow reserve (r = -0.434, p = 0.0115). A similar relationship was observed in non-ischaemic segments of CAD patients. Hyperinsulinaemia increased MBF to a similar extent in the non-ischaemic myocardial of CAD and HF patients. CONCLUSIONS/
INTERPRETATION: In type 2 diabetes, similar metabolic and perfusion patterns can be detected in the non-ischaemic regions of CAD patients with normal cardiac function and in the dysfunctional non-ischaemic myocardium of HF patients. This suggests that insulin resistance, rather than diagnosis of ischaemia or left ventricular dysfunction, affects the metabolism and perfusion features of patients with type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22752026     DOI: 10.1007/s00125-012-2631-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  28 in total

1.  Skeletal muscle microvascular recruitment by physiological hyperinsulinemia precedes increases in total blood flow.

Authors:  M A Vincent; D Dawson; A D H Clark; J R Lindner; S Rattigan; M G Clark; E J Barrett
Journal:  Diabetes       Date:  2002-01       Impact factor: 9.461

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations.

Authors:  C S Patlak; R G Blasberg
Journal:  J Cereb Blood Flow Metab       Date:  1985-12       Impact factor: 6.200

4.  Several factors associated with the insulin resistance syndrome are predictors of left ventricular systolic dysfunction in a male population after 20 years of follow-up.

Authors:  J Arnlöv; L Lind; B Zethelius; B Andrén; C N Hales; B Vessby; H Lithell
Journal:  Am Heart J       Date:  2001-10       Impact factor: 4.749

5.  Mismatch between insulin-mediated glucose uptake and blood flow in the heart of patients with Type II diabetes.

Authors:  P Iozzo; P Chareonthaitawee; O Rimoldi; D J Betteridge; P G Camici; E Ferrannini
Journal:  Diabetologia       Date:  2002-07-27       Impact factor: 10.122

6.  Insulin resistance and risk of congestive heart failure.

Authors:  Erik Ingelsson; Johan Sundström; Johan Arnlöv; Björn Zethelius; Lars Lind
Journal:  JAMA       Date:  2005-07-20       Impact factor: 56.272

7.  Glucose uptake and lumped constant variability in normal human hearts determined with [18F]fluorodeoxyglucose.

Authors:  H E Bøtker; M Böttcher; O Schmitz; A Gee; S B Hansen; G E Cold; T T Nielsen; A Gjedde
Journal:  J Nucl Cardiol       Date:  1997 Mar-Apr       Impact factor: 5.952

Review 8.  Diabetic cardiomyopathy revisited.

Authors:  Sihem Boudina; E Dale Abel
Journal:  Circulation       Date:  2007-06-26       Impact factor: 29.690

9.  Insulin resistance in idiopathic dilated cardiomyopathy: a possible etiologic link.

Authors:  Ronald M Witteles; W H Wilson Tang; Aamer H Jamali; James W Chu; Gerald M Reaven; Michael B Fowler
Journal:  J Am Coll Cardiol       Date:  2004-07-07       Impact factor: 24.094

10.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

Authors:  Perry Elliott; Bert Andersson; Eloisa Arbustini; Zofia Bilinska; Franco Cecchi; Philippe Charron; Olivier Dubourg; Uwe Kühl; Bernhard Maisch; William J McKenna; Lorenzo Monserrat; Sabine Pankuweit; Claudio Rapezzi; Petar Seferovic; Luigi Tavazzi; Andre Keren
Journal:  Eur Heart J       Date:  2007-10-04       Impact factor: 29.983

View more
  1 in total

1.  Effect of Dapagliflozin on Myocardial Insulin Sensitivity and Perfusion: Rationale and Design of The DAPAHEART Trial.

Authors:  Gian Pio Sorice; Francesca Cinti; Lucia Leccisotti; Domenico D'Amario; Margherita Lorusso; Maria Angela Guzzardi; Teresa Mezza; Camilla Cocchi; Umberto Capece; Pietro Manuel Ferraro; Filippo Crea; Alessandro Giordano; Patricia Iozzo; Andrea Giaccari
Journal:  Diabetes Ther       Date:  2021-05-26       Impact factor: 2.945

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.